Skip to main content

Table 1 Patient characteristics

From: Characteristics and outcomes of diabetic patients with an implantable cardioverter defibrillator in a real world setting: results from the Israeli ICD registry

 

Non-diabetics (%)

Diabetic (%)

p value

N

1346

764

 

Male

1215 (82)

726 (85)

0.033

Age (mean ± SD)

62.2 ± 14

66.3 ± 9.4

<0.001

Age ≥75

256 (19)

163 (21)

0.154

Prior VA

452 (34)

273 (31)

0.252

Primary prevention

901 (66)

589 (76)

<0.001

Ischemic heart disease

904 (67)

625 (82)

<0.001

History of AF

254 (19)

170 (22)

<0.001

Chronic lung disease

85 (6)

118 (16)

<0.001

Smoker

379 (29)

272 (36)

0.003

Dialysis

12 (1)

23 (4)

<0.001

Sleep apnea

81 (6)

89 (12)

<0.001

Prior CVA

98 (7)

67 (9)

<0.001

Atrial fibrillation

30 (2)

35 (1)

0.05

NYHA ≥3

377 (28)

326 (43)

<0.001

EF

30.5 ± 11.6

28.0 ± 8.3

<0.001

QRS duration

115.8 ± 29.8

124.6 ± 30.9

<0.01

CRTD

412 (31)

332 (43)

<0.001

ACE inhibitor

921 (69)

603 (79)

<0.001

Beta Blocker

1044 (78)

666 (87)

<0.001

  1. VA ventricular arrhythmia, CVA cerebrovascular accident, AF atrial fibrillation, NYHA New York Heart Association, EF ejection fraction, CRTD cardiac resynchronization therapy-defibrillator, ACE angiotensin converter enzyme